Cervomed Inc CRVO

$1.33 -0.12 (-8.28%)

Valuation

Market cap
21,937,000
Revenue TTM
$4,010,000
Net income TTM
$-26,970,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-672.57%
Debt to equity
0.00

Trading

Volume
284,800
Avg volume
556,526
Day's range
$1.33 – $1.52
Shares out
15,129,000
Stochastic %K
4%
Beta
-0.62
Analysts
Strong Buy
Price target
$17.83

Price

Company profile

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease...

Show more

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 744 4400
Website
https://www.cervomed.com
Address
20 Park Plaza, Suite 424, Boston, United States

Latest news

Stocktwits

BPler Nov 20, 1:36 PM
$ANT I hope the liquidity and profits made will go back to biotech/health soon (especially for $EVH and $CRVO were bleeding out hard for me. No surprise in case of CervoMed the CEO just insider bought 100k shares). But it was a big haircut last week. https://www.stocktitan.net/sec-filings/CRVO/form-4-cervo-med-inc-insider-trading-activity-6a88d58b0f17.html
0 replies
Mfv Nov 20, 12:31 PM
$CRVO A start.
0 replies
Doom_Gloom_AR Nov 20, 3:01 AM
$CRVO CEO open market buy, don't give up on this one gentlemen this is the loading zone.
2 replies
openmarketalerts Nov 20, 2:06 AM
$CRVO: $153K of stock bought by CEO Alam John J on Nov 18. • 100,000 shares at $1.53. • Bought 20% above the 52-week low. • Stake up 6.7%.
0 replies
Stu_padasso Nov 19, 7:05 PM
$CRVO -10, -5, -6 during the three trading days since the big data reveal market says: it sucks and even if ok no one will invest in this steaming pile of turd with meh results
0 replies
Scorpole Nov 19, 5:21 PM
$CRVO Billions of dollars have gone from biotec into AI. Now lot of those billions are gone now and will not go back to biotec. Many small biotec companies will be gone in the next 2-3 years. No money for them.
1 replies
Stu_padasso Nov 19, 5:01 PM
$CRVO under a buck by next week
1 replies
Scorpole Nov 19, 2:46 PM
$CRVO Last week pump and dump was just an attempt to get out before an offering is coming
1 replies